Estimates Revisions Amplia Therapeutics Limited
Stocks
ATX
AU0000023822
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1500 AUD | -3.23% |
|
0.00% | - |
| 12:38am | Amplia Therapeutics Limited Announces Appointment of Brett Carter to Board, Effective July 6, 2026 | CI |
| 07/07 | Amplia Therapeutics Limited Announces Board Changes, Effective June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- ATX Stock
- Consensus Amplia Therapeutics Limited
- Estimates Revisions
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
